Discussion of Assessing Heterogeneity of Treatment Effect, Estimating Patient-Specific Efficacy, and Studying Variation in Odds ratios, Risk Ratios, and Risk Differences
|
|
26
|
8684
|
February 22, 2023
|
RMS Multivariable Modeling Strategies
|
|
37
|
24069
|
January 26, 2023
|
RMS General Regression
|
|
52
|
24735
|
January 25, 2023
|
Interactions and random error
|
|
24
|
8555
|
October 20, 2022
|
Compare ORs between strata with log(OR) difference or use interactions?
|
|
0
|
605
|
July 21, 2022
|
Relative excess risk due to interaction (RERI) from a multiplicative model
|
|
3
|
1724
|
April 20, 2022
|
Making sense of significant interaction with null main effect in RCT
|
|
3
|
7452
|
December 24, 2020
|
Basic question regarding model specification for interaction testing using a Cox PH Model
|
|
6
|
2384
|
September 23, 2020
|
Subgroup Interaction
|
|
2
|
3076
|
April 8, 2020
|
RCT generalizability and interactions with treatment
|
|
8
|
4054
|
March 10, 2020
|
Bayesian Modeling of Patient-Specific Efficacy Estimates and HTE
|
|
2
|
3435
|
July 2, 2019
|
How to display and tabulate interaction effects in a longitudinal model
|
|
1
|
4060
|
December 14, 2018
|